Back to search

Anika Therapeutics Limited

11936143

active
Private Limited Company
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)

Details

SUITE 2, GROUND FLOOR, BRISTOL, BS1 6FL
Incorporated 09/04/2019

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

82990
Other business support service activities

Officers

Mr Stephen Douglas Griffin

director · Since 01/02/2026

AMERICAN · UNITED STATES · Age 40

Mr Ian Walter Mcleod

director · Since 01/02/2026

AMERICAN · UNITED STATES · Age 60

Persons with Significant Control

Anika Therapeutics, Inc

75–100% shares
75–100% votes
Appoint directors

32, Wiggins Avenue, Bedford

Reg: 000-21326 · Delaware, U.S. · Incorporated Entity

Notified 09/04/2019

CompanyRankvs 27996+ SIC 82990 peers
75

Financial strength93th percentile among SIC peers · 23/25
Employees95th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.56× · 16/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£464k

Balance sheet strength

Cash

£298k

Cash in the bank

Net Current Assets

£441k

Working capital

Current Assets

£1.2M

Current Liabilities

£794k

Fixed Assets

£23k

Debtors

£595k

Profit After Tax

£70k

9avg. employees-2

Tax at Year End

Corp tax£81k

Balance Sheet

Assets less current liabilities£464k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20241.56+£70k
20231.46+£145k
20211.73
20190.89

Derived from filed accounts. Not audited figures.